play_arrow

keyboard_arrow_right

Listeners:

Top listeners:

skip_previous skip_next
00:00 00:00
playlist_play chevron_left
volume_up
Go to album
  • play_arrow

    Omanyano ovanhu koikundaneki yomalungula kashili paveta, Commisiner Sakaria takunghilile Veronika Haulenga

Lenacapavir

7 Results / Page 1 of 1

Background
insert_link

Oshiwambo

UUministeli wuuhaku ouna omukumo mowenda yoku keelela o HIV yo lenacapavir

Uuministeli wuuhaku ouna omukumo kombinga yowenda yoku keelela o HIV o lenacapavir,ndjoka tayi ningilwa omalolelo miilongo ya Africa ya yooloka. Moshiluku shayo oshitiyali,owenda oyuulika iizemo tayi etitha oonkondo koohandimwe yena o HIV naamboka yaahena ombuto. Shiikwatelela ku Linda-Gail Bekker,omu Professor ko University of Cape town ,okwati omalolelo mo South Africa nomo Uganda oguulike kutya owenda tayigandjwa lwaali momumvo otayi gandja egameno lyuudha kyo HIV kaakiintu aagundjuka . Omalolelo oga yelekanitha […]

todayOctober 17, 2024 14

insert_link

Health / Medical

New HIV-AIDS Preventative Injection Shows Promising Results in African Trials

The Health ministry is optimistic about a new HIV-AIDS preventative injection, lenacapavir, currently undergoing trials in several African countries. In its second phase, the injection has shown promising results for both individuals living with HIV-AIDS and those uninfected. According to Linda-Gail Bekker, a professor at the University of Cape Town, trials in South Africa and Uganda indicate that a twice-yearly lenacapavir injection provides complete protection against HIV for young women. […]

todayOctober 17, 2024 35

insert_link

Health / Medical

Lenacapavir shows 96% HIV prevention success

A six-monthly HIV prevention injection containing lenacapavir has been confirmed effective in two pivotal studies. The first study, PURPOSE 1, showed no HIV infections among two-thousand-134 participants, while the second, PURPOSE 2, reported two infections among two-thousand-179 participants. This translates to a 96-percent reduction in HIV infections compared to background incidence. Gilead Sciences plans to file for regulatory approval to market lenacapavir for prevention. Separately, during a press briefing on Monday, the U.S. Department […]

todayOctober 15, 2024 42

insert_link

Oshiwambo

Owenda yoshingangamithi sho lenacapavir otayi vulu oku keelela o HIV

Owenda yoku keelela o HIV yoomwedhi 6 yina o lenacapavir oya kolekwa tayi longo ,momalolelo gopaali ga simana. Omapekapeko gotango,go Purpose1 oguulike pwaahena iipotha yo HIV maakuthimbinga 2 134,omanga omatiyali go PURPOSE 2,ga lopota iipotha 2 maakuthimbinga 2 179. Shika osha kalelapo eshonopeko lyoo % 96 lyiipotha yo HIV ,okuyeleka kiiniingwanima ya tetekele. O Gilead Sciences oya thaneka oku konga eziminino okuyela o lenacapavir oku keelela o HIV.  

todayOctober 15, 2024 29

insert_link 12 12

Oshiwambo

Otapa ningwa omalolelo gowenda tayi gandjwa lwaali momumvo okugamena aakiintu aagundjuka ko HIV

Omalolelo omanene ga ningwa mo South Africa nomo Uganda oguulike kutya owenda tayi gandjwa lwaali momvula otayi vulu okupa aakiintu aagundjuka egameno lyoo % 100 ko HIV. O SABC oya lopota kutya omalolelo otaga kongo oku tala ngele owenda yoomwedhi 6 yo lenacapavir otayi vulu okugandja egameno hwepo shi vulithe kiingangamithi yilwe yopaali,oopela hadhi nuwa lwaali mesiku ano o PrEP. Ospan yomapekapeko gopaunamiti okuza ko University of Cape town oya […]

todayJuly 25, 2024 39 12 12

insert_link

World

HIV breakthrough: drug trial shows injection twice a year is 100% effective against infection

    By Linda-Gail Bekker, University of Cape Town     A large clinical trial in South Africa and Uganda has shown that a twice-yearly injection of a new pre-exposure prophylaxis drug gives young women total protection from HIV infection. The trial tested whether the six-month injection of lenacapavir would provide better protection against HIV infection than two other drugs, both daily pills. All three medications are pre-exposure prophylaxis (or […]

todayJuly 3, 2024 34

insert_link

Health / Medical

Pharma firm urged to share new ‘game-changer’ HIV drug

          By Daniel Lawler Paris, May 30, 2024 (AFP) - More than 300 politicians, health experts and celebrities on Thursday called for US pharmaceutical giant Gilead to allow cheap, generic versions of a promising new HIV drug to be produced so it can reach people in developing countries most affected by the deadly disease. The drug lenacapavir could be a "real game-changer" in the fight against […]

todayMay 30, 2024 54

0%